Cargando…

Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial

BACKGROUND: Liver cirrhosis is a major healthcare problem and the mortality rate is high. During recent years, systemic inflammation has been recognized as a major driver of hepatic decompensation and progression of liver cirrhosis to acute-on-chronic liver failure (ACLF). The aim of the CYTOHEP stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekandarzad, Asieb, Weber, Enya, Prager, Eric Peter, Graf, Erika, Bettinger, Dominik, Wengenmayer, Tobias, Supady, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931566/ https://www.ncbi.nlm.nih.gov/pubmed/35303938 http://dx.doi.org/10.1186/s13063-022-06139-6

Ejemplares similares

Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
por: Sekandarzad, Asieb, et al.
Publicado: (2022)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
por: Supady, Alexander, et al.
Publicado: (2021)

Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study
por: Luxenburger, Hendrik, et al.
Publicado: (2022)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation
por: Rieder, Marina, et al.
Publicado: (2020)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial
por: Rieder, Marina, et al.
Publicado: (2021)

Cytokine adsorption and ECMO in patients with COVID-19 – Author's reply
por: Supady, Alexander
Publicado: (2021)

Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study
por: Yano, Rina, et al.
Publicado: (2023)

Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study
por: Hunyady, Peter, et al.
Publicado: (2022)

Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19
por: Supady, Alexander, et al.
Publicado: (2020)

Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2021)

Correction to: Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
por: Ito, Shuichi, et al.
Publicado: (2022)

On the Use of Hemadsorption with CytoSorb in Patients with Septic Shock. Comment on Kogelmann et al. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock. J. Clin. Med. 2021, 10, 2939
por: Supady, Alexander, et al.
Publicado: (2022)

Acute neurological care in north-east Germany with telemedicine support (ANNOTeM): protocol of a multi-center, controlled, open-label, two-arm intervention study
por: Weber, J. E., et al.
Publicado: (2020)

Hospital networks and patient transport capacity during the COVID-19 pandemic when intensive care resources become scarce
por: Supady, Alexander, et al.
Publicado: (2021)

Choosing the right reference cohort for assessing outcome of venovenous ECMO
por: Supady, Alexander, et al.
Publicado: (2022)

Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry
por: Supady, A., et al.
Publicado: (2023)

Dichloroacetate as a possible treatment for endometriosis-associated pain: a single-arm open-label exploratory clinical trial (EPiC)
por: Leow, H. W., et al.
Publicado: (2021)

Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC)
por: Kehmann, Linde, et al.
Publicado: (2023)

Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
por: Baig, Shanat, et al.
Publicado: (2018)

Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial
por: Stevens, Elizabeth R., et al.
Publicado: (2022)

Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial
por: Chen, Jie, et al.
Publicado: (2022)

Improving Airways Patency and Ventilation Through Optimal Positive Pressure Identified by Noninvasive Mechanical Ventilation Titration in Mounier-Kuhn Syndrome: Protocol for an Interventional, Open-Label, Single-Arm Clinical Trial
por: Lima, Evelise, et al.
Publicado: (2020)

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies
por: Beaton, Laura, et al.
Publicado: (2019)

Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial
por: Kamata, Yohei, et al.
Publicado: (2020)

Efficacy and Safety of Multi-Session Transcranial Direct Current Stimulation on Social Cognition in Schizophrenia: A Study Protocol for an Open-Label, Single-Arm Trial
por: Yamada, Yuji, et al.
Publicado: (2021)

Mobile ECMO retrieval of patients during the COVID‐19 pandemic
por: Widmeier, Eugen, et al.
Publicado: (2021)

The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma
por: Chen, Wenming, et al.
Publicado: (2022)

Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II)
Publicado: (2021)

PRObiotics and SYNbiotics to improve gut health and growth in infants in western Kenya (PROSYNK Trial): study protocol for a 4-arm, open-label, randomised, controlled trial
por: Otiti, Mary Iwaret, et al.
Publicado: (2022)

EnGraft: a multicentre, open-label, randomised, two-arm, superiority study protocol to assess bioavailability and practicability of Envarsus® versus Advagraf™ in liver transplant recipients
por: Wöhl, D. S., et al.
Publicado: (2023)

Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial
por: Crabb, Simon, et al.
Publicado: (2023)

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol
por: Karbhari, Aashna, et al.
Publicado: (2023)

THE DURATION OF MECHANICAL VENTILATION PRIOR TO VV-ECMO IN PATIENTS WITH COVID-19 DOES NOT HAVE AN IMPACT ON SURVIVAL DURING THREE WAVES OF THE PANDEMIC
por: WIDMEIER, E., et al.
Publicado: (2022)

Fully constrained acetabular liner vs. dual mobility hip joint in the surgical treatment of metastatic bone disease of the hip: study protocol for a randomized, open-label, two-arm, non-inferiority trial evaluating the post-operative hip dislocation rate
por: Iljazi, Afrim, et al.
Publicado: (2023)

Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial
por: Zablotska, Iryna B., et al.
Publicado: (2018)

Controlled automated reperfusion of the whole body after 120 minutes of Cardiopulmonary resuscitation: first clinical report
por: Trummer, Georg, et al.
Publicado: (2017)

Safety and Efficacy of Bis-Glyceryl Ascorbate (Amitose DGA) to Prevent Hand-Foot Skin Reaction in Patients With Renal Cell Carcinoma Receiving Sunitinib Therapy: Protocol for a Phase I/II, Uncontrolled, Single-Arm, Open-Label Trial
por: Yamamoto, Kazuhiro, et al.
Publicado: (2019)

A study protocol for evaluating the efficacy and safety of skin electrical stimulation for Leber hereditary optic neuropathy: a single-arm, open-label, non-randomized prospective exploratory study
por: Kurimoto, Takuji, et al.
Publicado: (2019)

Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
por: Shui, Lin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f3e5vulr399nbgc0fmtvcf03ua